Social Pressure and Perception The pressure to lose weight is nearly universal, but not evenly distributed
(2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Chao Liao, et al
At Kalos, your journey continues after you reach your goal weightbecause we understand that significant weight loss changes your body in ways that go beyond the number you see
Oncology Metabolism Research: In some preclinical cancer studies, researchers have observed retatrutide-associated weight changes alongside shifts in tumor-related metabolic outcomes
Research Overview Sema is a long-acting GLP-1 receptor agonist that has generated significant scientific interest due to its prolonged receptor activation and its role in metabolic signaling pathways
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus